🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/03/2014 | 53,73 | 53,97 | 53,59 | 53,78 | +0,18% | 0,71% | 7.410.303 |
| 17/03/2014 | 53,39 | 53,86 | 53,39 | 53,68 | +1,01% | 0,89% | 9.965.851 |
| 14/03/2014 | 52,99 | 53,45 | 52,74 | 53,15 | -0,16% | 1,35% | 12.699.454 |
| 13/03/2014 | 54,02 | 54,19 | 53,17 | 53,23 | -1,80% | 1,89% | 10.605.760 |
| 12/03/2014 | 53,81 | 54,32 | 53,68 | 54,21 | +0,21% | 1,19% | 9.954.218 |
| 11/03/2014 | 54,77 | 54,81 | 53,98 | 54,09 | -1,10% | 1,52% | 11.408.004 |
| 10/03/2014 | 54,81 | 54,98 | 54,39 | 54,69 | -0,26% | 1,08% | 7.737.594 |
| 07/03/2014 | 54,72 | 54,93 | 54,48 | 54,84 | +0,37% | 0,82% | 11.144.642 |
| 06/03/2014 | 54,45 | 55,01 | 54,40 | 54,64 | +0,67% | 1,12% | 11.114.774 |
| 05/03/2014 | 54,77 | 54,81 | 53,93 | 54,27 | -0,32% | 1,60% | 9.476.330 |
| 04/03/2014 | 54,43 | 54,76 | 54,30 | 54,45 | +1,13% | 0,84% | 11.523.703 |
| 03/03/2014 | 53,53 | 54,17 | 53,39 | 53,84 | -1,00% | 1,46% | 10.293.246 |
| 28/02/2014 | 54,13 | 54,83 | 54,06 | 54,38 | +0,58% | 1,43% | 12.457.157 |
| 27/02/2014 | 53,66 | 54,07 | 53,44 | 54,06 | +0,69% | 1,19% | 9.490.164 |
| 26/02/2014 | 53,44 | 53,86 | 53,36 | 53,69 | +0,64% | 0,95% | 10.626.196 |
| 25/02/2014 | 53,56 | 53,81 | 53,24 | 53,35 | -0,48% | 1,05% | 8.923.196 |
| 24/02/2014 | 53,31 | 54,31 | 53,31 | 53,61 | +0,27% | 1,88% | 11.541.100 |
| 21/02/2014 | 53,29 | 53,76 | 53,26 | 53,46 | +0,39% | 0,93% | 12.226.597 |
| 20/02/2014 | 52,59 | 53,44 | 52,51 | 53,25 | +1,40% | 1,76% | 10.619.489 |
| 19/02/2014 | 52,90 | 53,11 | 52,47 | 52,52 | -1,17% | 1,21% | 10.791.361 |
| 18/02/2014 | 52,69 | 53,37 | 52,61 | 53,14 | +0,45% | 1,45% | 11.738.753 |
| 14/02/2014 | 52,43 | 53,07 | 52,43 | 52,90 | +0,62% | 1,22% | 9.098.631 |
| 13/02/2014 | 51,96 | 52,68 | 51,92 | 52,58 | +0,18% | 1,47% | 10.735.083 |
| 12/02/2014 | 52,90 | 53,14 | 52,34 | 52,48 | -1,26% | 1,52% | 14.283.926 |
| 11/02/2014 | 52,20 | 53,20 | 51,95 | 53,15 | +1,48% | 2,39% | 16.089.525 |
| 10/02/2014 | 51,80 | 52,48 | 51,74 | 52,38 | +0,22% | 1,44% | 11.118.861 |
| 07/02/2014 | 51,19 | 52,31 | 50,99 | 52,26 | +1,86% | 2,57% | 15.192.961 |
| 06/02/2014 | 50,82 | 51,40 | 50,38 | 51,31 | +0,45% | 2,01% | 12.832.550 |
| 05/02/2014 | 51,79 | 52,67 | 50,71 | 51,08 | +0,04% | 3,80% | 25.682.602 |
| 04/02/2014 | 50,18 | 51,07 | 50,00 | 51,06 | +2,75% | 2,13% | 19.054.631 |